# Biotech Daily Digest — 2025-09-25

**36 items from 4 sources**

## Summary by Source

- Endpoints News: 8 items
- Fierce Biotech: 6 items
- MHRA – News: 1 item
- arXiv q-bio: 21 items


## Endpoints News

- **[Epic embraces the newfound attention of its AI tools](https://endpoints.news/epic-embraces-the-new-attention-its-ai-tools-have-gotten/)**  
  _Thu, 25 Sep 2025 13:00:26 +0000_  
  When electronic health record giant Epic revealed a suite of AI tools at its annual conference in August, the healthcare industry was closely watching. But a lot of it is not entirely new, VP of ...

- **[Merck KGaA CEO Belén Garijo to leave next May, when electronics unit leader will take the helm](https://endpoints.news/merck-kgaa-ceo-belen-garijo-to-leave-next-may-when-electronics-unit-leader-will-take-the-helm/)**  
  _Thu, 25 Sep 2025 11:25:21 +0000_  
  Belén Garijo will hand over the CEO post at Merck KGaA to the German healthcare conglomerate's electronics unit leader on May 1, 2026, the company said Thursday.

 Kai Beckmann, who's been ...

- **[PepGen seeks funds on the back of early-stage data in muscle wasting disease](https://endpoints.news/pepgen-seeks-funds-on-the-back-of-early-stage-data-in-muscle-wasting-disease/)**  
  _Thu, 25 Sep 2025 10:28:11 +0000_  
  PepGen posted positive data from an early-stage trial of its oligonucleotide for a rare muscle wasting condition Wednesday. It also announced a $100 million follow-on offering soon after.

 The Boston-based biotech' ...

- **[Hansa’s kidney transplant drug succeeds in Phase 3 trial in US](https://endpoints.news/hansas-kidney-transplant-drug-succeeds-phase-3-trial-in-us/)**  
  _Thu, 25 Sep 2025 08:36:14 +0000_  
  An immune antibody-cleaving drug from Hansa Biopharma could soon make it easier for some patients to get kidney transplants in the US.

 The Swedish biotech reported Wednesday that its drug imlifidase ...

- **[Biopharma industry tries to parse impact of Trump crackdown on H-1B visas](https://endpoints.news/biopharma-industry-tries-to-parse-impact-of-trump-crackdown-on-h-1b-visas/)**  
  _Wed, 24 Sep 2025 20:12:09 +0000_  
  Days after the Trump administration announced its plan to overhaul a specialty worker visa process, the biopharma industry is still trying to calculate what effect it will have on companies and workers.

 On Friday, President ...

- **[Immuneering builds momentum with additional first-line pancreatic cancer data, aims for Phase 3 this year](https://endpoints.news/immuneering-builds-momentum-with-additional-first-line-pancreatic-cancer-data-aims-for-phase-3-this-year/)**  
  _Wed, 24 Sep 2025 20:02:25 +0000_  
  Immuneering said Wednesday its MEK inhibitor pill helped keep 86% of pancreatic cancer patients alive at nine months when given in the first-line setting along with chemotherapy in a mid-stage trial.

 The drug, called atebimetinib ...

- **[AstraZeneca files to try to bring IRA fight to Supreme Court](https://endpoints.news/astrazeneca-files-to-try-to-bring-ira-fight-to-supreme-court/)**  
  _Wed, 24 Sep 2025 19:25:34 +0000_  
  AstraZeneca asked the US Supreme Court to review its challenge to Medicare drug price negotiations, escalating the long-running legal battle between pharma and the government over the law.

 The company said in its

- **[FDA unveils trio of new draft guidances to help cell and gene therapy developers](https://endpoints.news/fda-unveils-trio-of-new-draft-guidances-to-help-cell-and-gene-therapy-developers/)**  
  _Wed, 24 Sep 2025 17:30:04 +0000_  
  The FDA's biologics center on Wednesday offered its latest recommendations to help streamline the development of novel cell and gene therapies for small patient populations, as well as guidance on expediting programs for regenerative therapies ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/eli-lilly-withdraws-phase-2b-trial-19b-obesity-bet-starting-enrollment" hreflang="en">Eli Lilly withdraws phase 2b trial of $1.9B obesity bet before starting enrollment</a>](https://www.fiercebiotech.com/biotech/eli-lilly-withdraws-phase-2b-trial-19b-obesity-bet-starting-enrollment)**  
  _Sep 25, 2025 8:08am_  
  Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in its $1.9 billion Versanis buyout, as a single agent and in combination with blockbuster GLP-1/GIP drug tirzepatide.

- **[<a href="https://www.fiercebiotech.com/biotech/evaxion-offloads-vaccine-candidate-merck-592-million-biobucks" hreflang="en">Evaxion offloads vaccine candidate to Merck for $592M biobucks</a>](https://www.fiercebiotech.com/biotech/evaxion-offloads-vaccine-candidate-merck-592-million-biobucks)**  
  _Sep 24, 2025 3:58pm_  
  Merck & Co. is choosing to license one of Evaxion’s AI platform-based vaccine candidates, offering the Danish biotech up to $592 million for rights to the preclinical asset.

- **[<a href="https://www.fiercebiotech.com/medtech/lantheus-hands-ge-healthcare-rights-its-blockbuster-prostate-cancer-pet-tracer-japan" hreflang="en">Lantheus hands GE HealthCare the rights to its blockbuster prostate cancer PET tracer in Japan</a>](https://www.fiercebiotech.com/medtech/lantheus-hands-ge-healthcare-rights-its-blockbuster-prostate-cancer-pet-tracer-japan)**  
  _Sep 24, 2025 11:17am_  
  Lantheus inked a deal giving GE HealthCare the rights to its Pylarify prostate cancer PET imaging agent in Japan, which plans to pull it up through its recent Nihon Medi-Physics acquisition.

- **[<a href="https://www.fiercebiotech.com/biotech/sparrow-flits-forward-95m-series-b-midstage-diabetes-asset" hreflang="en">Sparrow flies forward with $95M series B for midstage diabetes asset</a>](https://www.fiercebiotech.com/biotech/sparrow-flits-forward-95m-series-b-midstage-diabetes-asset)**  
  _Sep 24, 2025 10:50am_  
  Sparrow Pharmaceuticals is looking to send its potential diabetes treatment soaring through clinical trials with the help of a $95 million series B, the company announced in a Sept. 24 release.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-25" hreflang="en">Fierce Biotech Fundraising Tracker '25: Sparrow secures $95M; Avenzo adds $60M</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-25)**  
  _Dec 23, 2024 12:22pm_  
  The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025" hreflang="en">Fierce Biotech Layoff Tracker 2025: Heidelberg reduces headcount by 75%; Rome nears end of road</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025)**  
  _Dec 23, 2024 11:52am_  
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.


## MHRA – News

- **[Millions of vaccines to be made in Oxfordshire, and government unveils £50 million fund, in double boost for life sciences](https://www.gov.uk/government/news/millions-of-vaccines-to-be-made-in-oxfordshire-and-government-unveils-50-million-fund-in-double-boost-for-life-sciences)**  
  _2025-09-24T23:00:00Z_  
  New Moderna Innovation and Technology Centre opened as government further boosts life sciences sector with £50 million fund.


## arXiv q-bio

- **[The Impact of Structural Changes on Learning Capacity in the Fly Olfactory Neural Circuit](https://arxiv.org/abs/2509.19351)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19351v1 Announce Type: new 
Abstract: The Drosophila mushroom body (MB) is known to be involved in olfactory learning and memory; the synaptic plasticity of the Kenyon cell (KC) to mushroom body output neuron (MBON) synapses plays a key role in the learning process. Previous research has focused on projecti…

- **[Deep Clustering for Blood Cell Classification and Quantification](https://arxiv.org/abs/2509.19399)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19399v1 Announce Type: new 
Abstract: Accurate classification of blood cells plays a key role in improving automated blood analysis for both medical and veterinary applications. This work presents a two-stage deep clustering method for classifying blood cells from high-dimensional signal data. In the first…

- **[Meta-analysis and Topological Perturbation in Interactomic Network for Anti-opioid Addiction Drug Repurposing](https://arxiv.org/abs/2509.19410)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19410v1 Announce Type: new 
Abstract: The ongoing opioid crisis highlights the urgent need for novel therapeutic strategies that can be rapidly deployed. This study presents a novel approach to identify potential repurposable drugs for the treatment of opioid addiction, aiming to bridge the gap between tran…

- **[Integrating Mechanistic Modeling and Machine Learning to Study CD4+/CD8+ CAR-T Cell Dynamics with Tumor Antigen Regulation](https://arxiv.org/abs/2509.19536)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19536v1 Announce Type: new 
Abstract: Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematological malignancies, yet patient responses remain highly variable and the roles of CD4 and CD8 subsets are not fully understood. We present an extended mathematical framework of CAR-T…

- **[Dynamicasome: a molecular dynamics-guided and AI-driven pathogenicity prediction catalogue for all genetic mutations](https://arxiv.org/abs/2509.19766)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19766v1 Announce Type: new 
Abstract: Advances in genomic medicine accelerate the identi cation of mutations in disease-associated genes, but the pathogenicity of many mutations remains unknown, hindering their use in diagnostics and clinical decision-making. Predictive AI models are generated to combat thi…

- **[A Foundation Chemical Language Model for Comprehensive Fragment-Based Drug Discovery](https://arxiv.org/abs/2509.19586)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19586v1 Announce Type: cross 
Abstract: We introduce FragAtlas-62M, a specialized foundation model trained on the largest fragment dataset to date. Built on the complete ZINC-22 fragment subset comprising over 62 million molecules, it achieves unprecedented coverage of fragment chemical space. Our GPT-2 bas…

- **[Evolution of phenocopying in a dynamical model of developmental trajectories](https://arxiv.org/abs/2509.19720)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19720v1 Announce Type: cross 
Abstract: Developmental trajectories are known to be canalized, or robust to both environmental and genetic perturbations. However, even when these trajectories are decanalized by an environmental perturbation outside of the range of conditions to which they are robust, they of…

- **[BioBO: Biology-informed Bayesian Optimization for Perturbation Design](https://arxiv.org/abs/2509.19988)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.19988v1 Announce Type: cross 
Abstract: Efficient design of genomic perturbation experiments is crucial for accelerating drug discovery and therapeutic target identification, yet exhaustive perturbation of the human genome remains infeasible due to the vast search space of potential genetic interactions and…

- **[A decision-theoretic framework for uncertainty quantification in epidemiological modelling](https://arxiv.org/abs/2509.20013)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.20013v1 Announce Type: cross 
Abstract: Estimating, understanding, and communicating uncertainty is fundamental to statistical epidemiology, where model-based estimates regularly inform real-world decisions. However, sources of uncertainty are rarely formalised, and existing classifications are often define…

- **[First-Extinction Law for Resampling Processes](https://arxiv.org/abs/2509.20101)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.20101v1 Announce Type: cross 
Abstract: Extinction times in resampling processes are fundamental yet often intractable, as previous formulas scale as $2^M$ with the number of states $M$ present in the initial probability distribution. We solve this by treating multinomial updates as independent square-root…

- **[Ising dynamics on multilayer networks with heterogeneous layers](https://arxiv.org/abs/2509.20216)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.20216v1 Announce Type: cross 
Abstract: Multilayer networks provide a framework to study complex systems with multiple types of interactions, multiple dynamical processes, and/or multiple subsystems. When studying a dynamical process on a multilayer network, it is important to consider how both layer struct…

- **[A co-evolving agentic AI system for medical imaging analysis](https://arxiv.org/abs/2509.20279)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.20279v1 Announce Type: cross 
Abstract: Agentic AI is rapidly advancing in healthcare and biomedical research. However, in medical image analysis, their performance and adoption remain limited due to the lack of a robust ecosystem, insufficient toolsets, and the absence of real-time interactive expert feedb…

- **[PGCLODA: Prompt-Guided Graph Contrastive Learning for Oligopeptide-Infectious Disease Association Prediction](https://arxiv.org/abs/2509.20290)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2509.20290v1 Announce Type: cross 
Abstract: Infectious diseases continue to pose a serious threat to public health, underscoring the urgent need for effective computational approaches to screen novel anti-infective agents. Oligopeptides have emerged as promising candidates in antimicrobial research due to their…

- **[Discrete vs. continuous dynamics in biology: When do they align and when do they diverge?](https://arxiv.org/abs/2411.11602)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2411.11602v3 Announce Type: replace 
Abstract: Many biological systems are governed by difference equations and exhibit discrete-time dynamics. Examples include the size of a population when generations are non-overlapping, and the incidence of a disease when infections are recorded at fixed intervals. For discr…

- **[Deciphering Functions of Neurons in Vision-Language Models](https://arxiv.org/abs/2502.18485)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2502.18485v4 Announce Type: replace 
Abstract: The burgeoning growth of open-sourced vision-language models (VLMs) has catalyzed a plethora of applications across diverse domains. Ensuring the transparency and interpretability of these models is critical for fostering trustworthy and responsible AI systems. In t…

- **[PathGene: Benchmarking Driver Gene Mutations and Exon Prediction Using Multicenter Lung Cancer Histopathology Image Dataset](https://arxiv.org/abs/2506.00096)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2506.00096v2 Announce Type: replace 
Abstract: Accurately predicting gene mutations, mutation subtypes and their exons in lung cancer is critical for personalized treatment planning and prognostic assessment. Faced with regional disparities in medical resources and the high cost of genomic assays, using artifici…

- **[Suppression of errors in collectively coded information](https://arxiv.org/abs/2508.21806)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2508.21806v2 Announce Type: replace 
Abstract: Modern life largely transmits genetic information from mother to daughter through the duplication of single physically intact molecules that encode information. However, copying an extended molecule requires complex copying machinery and high fidelity that scales wi…

- **[Runtime Analysis of Competitive co-Evolutionary Algorithms for Maximin Optimisation of a Bilinear Function](https://arxiv.org/abs/2206.15238)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2206.15238v3 Announce Type: replace-cross 
Abstract: Co-evolutionary algorithms have a wide range of applications, such as in hardware design, evolution of strategies for board games, and patching software bugs. However, these algorithms are poorly understood and applications are often limited by pathological be…

- **[Chase-and-Run and Chirality in Nonlocal Models of Pattern Formation](https://arxiv.org/abs/2505.17372)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2505.17372v2 Announce Type: replace-cross 
Abstract: Chase-and-run dynamics, in which one population pursues another that flees from it, are found throughout nature, from predator-prey interactions in ecosystems to the collective motion of cells during development. Intriguingly, in many of these systems, the mov…

- **[Multi-Modal Artificial Intelligence of Embryo Grading and Pregnancy Prediction in Assisted Reproductive Technology: A Review](https://arxiv.org/abs/2505.20306)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2505.20306v2 Announce Type: replace-cross 
Abstract: Infertility, a pressing global health concern, affects a substantial proportion of individuals worldwide. While advancements in assisted reproductive technology (ART) have offered effective interventions, conventional in vitro fertilization-embryo transfer (IV…

- **[Assay2Mol: large language model-based drug design using BioAssay context](https://arxiv.org/abs/2507.12574)**  
  _Thu, 25 Sep 2025 00:00:00 -0400_  
  arXiv:2507.12574v2 Announce Type: replace-cross 
Abstract: Scientific databases aggregate vast amounts of quantitative data alongside descriptive text. In biochemistry, molecule screening assays evaluate candidate molecules' functional responses against disease targets. Unstructured text that describes the biological…
